Figure 5.
Host iNKT cells are required for GVHD protection after α-GalCer-lipo treatment. (A) T cell–depleted BM cells (BMCs) and Tcons isolated from C57BL/6 Jα18−/− mice (H2b) were transferred into WT BALB/c mice (H2d) together with purified Foxp3GFP+ Tregs that were obtained from C57BL/6 Foxp3GFP+ mice (H2b). (B) T cell–depleted BMCs and Tcons were obtained from WT C57BL/6 donor mice (H2b) and transferred into BALB/c Jα18−/− mice (H2d) together with C57BL/6 Foxp3GFP+ Tregs (H2b). Ctrl-lipo (blue) or α-GalCer-lipo (red) was injected right after cell transfer. Pooled data from 2 independent experiments. **P < .01 by log-rank test between 2 indicated groups.

Host iNKT cells are required for GVHD protection after α-GalCer-lipo treatment. (A) T cell–depleted BM cells (BMCs) and Tcons isolated from C57BL/6 Jα18−/− mice (H2b) were transferred into WT BALB/c mice (H2d) together with purified Foxp3GFP+ Tregs that were obtained from C57BL/6 Foxp3GFP+ mice (H2b). (B) T cell–depleted BMCs and Tcons were obtained from WT C57BL/6 donor mice (H2b) and transferred into BALB/c Jα18−/− mice (H2d) together with C57BL/6 Foxp3GFP+ Tregs (H2b). Ctrl-lipo (blue) or α-GalCer-lipo (red) was injected right after cell transfer. Pooled data from 2 independent experiments. **P < .01 by log-rank test between 2 indicated groups.

Close Modal

or Create an Account

Close Modal
Close Modal